The Menlo Park-based biotech is developing a therapy for non-tuberculous mycobacterial (NTM) lung disease, which typically attacks older people or ...
News
- Menlo Park biotech AN2 Therapeutics files plans to go public - The Business Journals
- Houston organization doles out over $775,000 in prices to women-led health tech startups ...
San Antonio-based Hera Biotech took third place and was awarded a pilot program prize with Banner Health. Hera has developed the first ...
- CVS Health to Invest $15.3 Million in Affordable Housing in San Antonio - PR Newswire
PRNewswire/ -- CVS Health (NYSE: CVS) today announced it will invest more than $15.3 million with Pedcor Investments and WNC to build 312 new ...
- Cellular rejuvenation therapy safely reverses signs of aging in mice - EurekAlert!
“In addition to tackling age-related diseases, this approach may provide the biomedical community with a new tool to restore tissue and organismal ...
- Building 'South Texas Triangle'? Geekdom looks south to recruit startups
By 2011, Rackspace Technology co-founder Graham Weston had faced years of hiring problems in San Antonio. Rackspace struggled to find workers for ...